Real-world Scenario: CROSS Regimen as Preoperative Therapy for Oesophageal Squamous Cell Carcinoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Surgery
Link
https://link.springer.com/content/pdf/10.1007/s11605-020-04704-5.pdf
Reference27 articles.
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018. doi:https://doi.org/10.3322/caac.21492.
2. Wang QL, Xie SH, Wahlin K, Lagergren J. Global time trends in the incidence of esophageal squamous cell carcinoma. Clinical Epidemiology. 2018;10:717-28. doi:https://doi.org/10.2147/clep.S166078.
3. Wong I, Law S. The management of mid & proximal oesophageal squamous cell carcinoma. Best Practice & Research Clinical Gastroenterology. 2018;36-37:85-90. doi:https://doi.org/10.1016/j.bpg.2018.11.012.
4. Law S, Fok M, Chow S, Chu KM, Wong J. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg. 1997;114(2):210-7. doi:https://doi.org/10.1016/s0022-5223(97)70147-8.
5. Law S, Kwong DL, Kwok KF, Wong KH, Chu KM, Sham JS et al. Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg. 2003;238(3):339-47; discussion 47-8. doi:https://doi.org/10.1097/01.sla.0000086545.45918.ee.
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma in Eastern versus Western countries: meta-analysis;British Journal of Surgery;2024-05
2. Comparison of therapeutic outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy: A prospective observational cohort study;Journal of the Formosan Medical Association;2024-01
3. Collaborative multidisciplinary management and expertise of cT2–3 locally advanced operable esophageal squamous cell carcinoma: a report of two cases;Journal of Thoracic Disease;2023-11
4. Reproducibility of the CROSS Trial Results in the Multimodal Treatment of Esophageal Cancer in Daily Practice: A Single Center Retrospective Observational Study;Journal of Oncology;2023-01-30
5. Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric Cancers;Gastrointestinal Tumors;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3